← All Acurx Pharmaceuticals, INC filings

Acurx Pharmaceuticals, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
ACXP
Acurx Pharmaceuticals, INC
DEFA14A: Acurx Seeks Shareholder Vote on Warrant Issuance, Stock Increase
Acurx Pharmaceuticals, Inc. is seeking shareholder approval for the issuance of shares related to Series G-2 warrants and an increase in its authorized common stock ahead of its September 16, 2025 Special Meeting.
NASDAQ
ACXP
Acurx Pharmaceuticals, INC
DEF: Acurx Seeks Shareholder Approval for Capital Raise
Acurx Pharmaceuticals, Inc. is seeking stockholder approval for a significant common stock issuance related to a recent financing and an increase in authorized shares to support future corporate actions.
NASDAQ
ACXP
Acurx Pharmaceuticals, INC
DEFA14A: Acurx Pharmaceuticals Seeks Shareholder Approval for Reverse Stock Split and Significant Capital Raises
Acurx Pharmaceuticals, Inc. is seeking shareholder approval for a reverse stock split, significant share issuances for capital raising, and an increase in its equity incentive plan ahead of its 2025 Annual Meeting.
NASDAQ
ACXP
Acurx Pharmaceuticals, INC
DEF: Acurx Pharmaceuticals Seeks Shareholder Approval for Reverse Stock Split and Major Capital Raises to Maintain Nasdaq Listing and Fund Operations
Acurx Pharmaceuticals, Inc. is calling its 2025 Annual Meeting to approve a reverse stock split to regain Nasdaq compliance, authorize significant share issuances for capital, and expand its equity incentive plan.
NASDAQ
ACXP
Acurx Pharmaceuticals, INC
DEFA14A: Acurx Pharmaceuticals Sets Date for 2024 Annual Meeting, Outlines Voting Proposals
Acurx Pharmaceuticals announces its 2024 Annual Meeting of Stockholders to be held virtually on June 17, 2024, with proposals including the election of directors and ratification of independent auditors.
NASDAQ
ACXP
Acurx Pharmaceuticals, INC
DEF 14A: Acurx Pharmaceuticals Sets Date for 2024 Annual Stockholders Meeting
Acurx Pharmaceuticals announces its 2024 annual meeting of stockholders to be held virtually on June 17, 2024, focusing on director elections and auditor ratification.